{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T02:49:34Z","timestamp":1772160574852,"version":"3.50.1"},"reference-count":71,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1523,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1111\/j.1742-1241.2011.02731.x","type":"journal-article","created":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T04:22:04Z","timestamp":1309494124000},"page":"1005-1013","source":"Crossref","is-referenced-by-count":41,"title":["Current benign prostatic hyperplasia treatment: impact on sexual function and management of related sexual adverse events"],"prefix":"10.1155","volume":"65","author":[{"given":"V.","family":"Mirone","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Sessa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Giuliano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Berges","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Kirby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Moncada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,7,1]]},"reference":[{"key":"10.1111\/j.1742-1241.2011.02731.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/S0022-5347(01)67448-2","article-title":"Natural history of prostatism: relationship among symptoms, prostate volume and peak urinary flow rate","volume":"153","author":"Girman","year":"1995","journal-title":"J Urol"},{"key":"10.1111\/j.1742-1241.2011.02731.x-BIB2|cit2","volume-title":"Guidelines on Conservative Treatment of Non-neurogenic Male LUTS","author":"Oelke","year":"2010"},{"key":"10.1111\/j.1742-1241.2011.02731.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/j.1464-410X.2004.04765.x","article-title":"Guideline for the primary care management of male lower urinary tract symptoms","volume":"93","author":"Speakman","year":"2004","journal-title":"BJU Int"},{"key":"10.1111\/j.1742-1241.2011.02731.x-BIB4|cit4","first-page":"S122","article-title":"BPH: epidemiology and comorbidities","volume":"12","author":"McVary","year":"2006","journal-title":"Am J Manag Care"},{"key":"10.1111\/j.1742-1241.2011.02731.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1111\/j.1743-6109.2009.01601.x","article-title":"Age-related changes in general and sexual health in middle-aged and older men: results from the European Male Ageing Study (EMAS)","volume":"7","author":"Corona","year":"2010","journal-title":"J Sex Med"},{"key":"10.1111\/j.1742-1241.2011.02731.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S0022-5347(05)67900-1","article-title":"Incidence of erectile dysfunction in men 40 to 69\u2003years old: longitudinal results from the Massachusetts Male Aging Study","volume":"163","author":"Johannes","year":"2000","journal-title":"J Urol"},{"key":"10.1111\/j.1742-1241.2011.02731.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0090-4295(00)01091-8","article-title":"Erectile and ejaculatory dysfunction in a community-based sample of men 50 to 78\u2003years old: prevalence, concern, and relation to sexual activity","volume":"57","author":"Blanker","year":"2001","journal-title":"Urology"},{"key":"10.1111\/j.1742-1241.2011.02731.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1111\/j.1464-410X.2007.06803.x","article-title":"Determinants of ejaculatory dysfunction in a community-based longitudinal study","volume":"99","author":"Gan","year":"2007","journal-title":"BJU Int"},{"key":"10.1111\/j.1742-1241.2011.02731.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1111\/j.1464-410X.2008.07498.x","article-title":"Profile and management of patients treated for the first time for lower urinary tract symptoms\/benign prostatic hyperplasia in four European Countries","volume":"101","author":"Fourcade","year":"2008","journal-title":"BJU Int"},{"key":"10.1111\/j.1742-1241.2011.02731.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1464-410X.2007.06609.x","article-title":"The impact of lower urinary tract symptoms and comorbidities on quality of life: the BACH and UREPIK studies","volume":"99","author":"Robertson","year":"2007","journal-title":"BJU Int"},{"key":"10.1111\/j.1742-1241.2011.02731.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/sj.ijir.3901197","article-title":"Quality of life, mood, and sexual function: a path analytic model of treatment effects in men with erectile dysfunction and depressive symptoms","volume":"16","author":"Rosen","year":"2004","journal-title":"Int J Impot Res"},{"key":"10.1111\/j.1742-1241.2011.02731.x-BIB12|cit12","first-page":"1","volume-title":"Guideline on the Management of Benign Prostatic Hyperplasia (BPH)","author":"AUA Practice Guidelines Committee","year":"2006"},{"issue":"Suppl. 2","key":"10.1111\/j.1742-1241.2011.02731.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1464-410X.2006.06104.x","article-title":"Impact of medical treatments for benign prostatic hyperplasia on sexual function","volume":"97","author":"Giuliano","year":"2006","journal-title":"BJU Int"},{"key":"10.1111\/j.1742-1241.2011.02731.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/01.mou.0000193366.53705.ce","article-title":"Update on the relationship between sexual dysfunction and lower urinary tract symptoms\/benign prostatic hyperplasia","volume":"16","author":"Rosen","year":"2006","journal-title":"Curr Opin Urol"},{"key":"10.1111\/j.1742-1241.2011.02731.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.urology.2008.05.034","article-title":"Association of sexual dysfunction with lower urinary tract symptoms of BPH and BPH medical therapies: results from the BPH Registry","volume":"73","author":"Rosen","year":"2009","journal-title":"Urology"},{"key":"10.1111\/j.1742-1241.2011.02731.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/S0302-2838(03)00358-0","article-title":"Lower urinary tract symptoms and erectile dysfunction: co-morbidity or typical \u2018Aging Male\u2019 symptoms? Results of the \u2018Cologne Male Survey\u2019","volume":"44","author":"Braun","year":"2003","journal-title":"Eur Urol"},{"key":"10.1111\/j.1742-1241.2011.02731.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.eururo.2003.08.015","article-title":"Lower urinary tract symptoms and male sexual dysfunction: the Multinational Survey of the Aging Male (MSAM-7)","volume":"44","author":"Rosen","year":"2003","journal-title":"Eur Urol"},{"issue":"Suppl. 3","key":"10.1111\/j.1742-1241.2011.02731.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1464-410X.2009.08447.x","article-title":"The impact of lower urinary tract symptoms on male sexual health: EpiLUTS","volume":"103","author":"Wein","year":"2009","journal-title":"BJU Int"},{"key":"10.1111\/j.1742-1241.2011.02731.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1111\/j.1743-6109.2008.01120.x","article-title":"Increased sexual dysfunction in men with storage and voiding lower urinary tract symptoms","volume":"6","author":"Morant","year":"2009","journal-title":"J Sex Med"},{"key":"10.1111\/j.1742-1241.2011.02731.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1080\/01485010500379871","article-title":"Association between lower urinary tract symptoms and erectile dysfunction","volume":"52","author":"Aslan","year":"2006","journal-title":"Arch Androl"},{"key":"10.1111\/j.1742-1241.2011.02731.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.eururo.2005.02.001","article-title":"Erectile dysfunction and lower urinary tract symptoms secondary to BPH","volume":"47","author":"McVary","year":"2005","journal-title":"Eur Urol"},{"key":"10.1111\/j.1742-1241.2011.02731.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/BF00297196","article-title":"Nitric oxide synthase activity in the human urogenital tract","volume":"22","author":"Ehren","year":"1994","journal-title":"Urol Res"},{"key":"10.1111\/j.1742-1241.2011.02731.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/S0090-4295(99)80013-2","article-title":"Effects of nitric oxide on human and canine prostates","volume":"45","author":"Takeda","year":"1995","journal-title":"Urology"},{"key":"10.1111\/j.1742-1241.2011.02731.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.urology.2007.10.051","article-title":"Effects of phosphodiesterase inhibitors on tension induced by norepinephrine and accumulation of cyclic nucleotides in isolated human prostatic tissue","volume":"71","author":"Uckert","year":"2008","journal-title":"Urology"},{"key":"10.1111\/j.1742-1241.2011.02731.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1210\/en.2006-1079","article-title":"Characterization and functional role of androgen-dependent PDE5 activity in the bladder","volume":"148","author":"Filippi","year":"2007","journal-title":"Endocrinology"},{"key":"10.1111\/j.1742-1241.2011.02731.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.urology.2008.06.060","article-title":"Relaxant effects of sildenafil on the human isolated bladder neck","volume":"73","author":"Bittencourt","year":"2009","journal-title":"Urology"},{"key":"10.1111\/j.1742-1241.2011.02731.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1124\/mol.53.3.467","article-title":"Antiproliferative effect in human prostatic smooth muscle cells by nitric oxide donor","volume":"53","author":"Guh","year":"1998","journal-title":"Mol Pharmacol"},{"key":"10.1111\/j.1742-1241.2011.02731.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2165\/00003495-200868020-00005","article-title":"Guide to drug therapy for lower urinary tract symptoms in patients with benign prostatic obstruction. Implications for sexual function","volume":"68","author":"Gur","year":"2008","journal-title":"Drugs"},{"key":"10.1111\/j.1742-1241.2011.02731.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1097\/01.ju.0000085024.47406.6c","article-title":"Y-27632, a Rho-kinase inhibitor, inhibits proliferation and adrenergic contraction of prostatic smooth muscle cells","volume":"170","author":"Rees","year":"2003","journal-title":"J Urol"},{"key":"10.1111\/j.1742-1241.2011.02731.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"R1124","DOI":"10.1152\/ajpregu.00717.2003","article-title":"Increased corpus cavernosum smooth muscle tone associated with partial bladder outlet obstruction is mediated via Rho-kinase","volume":"289","author":"Chang","year":"2005","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1111\/j.1742-1241.2011.02731.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/sj.pcan.4500221","article-title":"Components of the metabolic syndrome - risk factors for the development of benign prostatic hyperplasia","volume":"1","author":"Hammarsten","year":"1998","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1111\/j.1742-1241.2011.02731.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0140-6736(05)67402-8","article-title":"The metabolic syndrome - a new worldwide definition","volume":"366","author":"Alberti","year":"2005","journal-title":"Lancet"},{"key":"10.1111\/j.1742-1241.2011.02731.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.juro.2009.04.025","article-title":"Association of lower urinary tract symptoms and the metabolic syndrome: results from the Boston Area Community Health Survey","volume":"182","author":"Kupelian","year":"2009","journal-title":"J Urol"},{"key":"10.1111\/j.1742-1241.2011.02731.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1002\/nau.20892","article-title":"Overactive bladder: is there a link to the metabolic syndrome in men?","volume":"29","author":"Kirby","year":"2010","journal-title":"Neurourol Urodyn"},{"key":"10.1111\/j.1742-1241.2011.02731.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/s11906-008-0083-1","article-title":"Mediators of sympathetic activation in metabolic syndrome obesity","volume":"10","author":"Straznicky","year":"2008","journal-title":"Curr Hypertens Rep"},{"key":"10.1111\/j.1742-1241.2011.02731.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1095\/biolreprod51.1.99","article-title":"Growth of the prostate gland is facilitated by the autonomic nervous system","volume":"51","author":"McVary","year":"1994","journal-title":"Biol Reprod"},{"key":"10.1111\/j.1742-1241.2011.02731.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/j.1939-4640.2000.tb03276.x","article-title":"Spontaneous hyperplasia of the ventral lobe of the prostate in aging genetically hypertensive rats","volume":"21","author":"Golomb","year":"2000","journal-title":"J Androl"},{"key":"10.1111\/j.1742-1241.2011.02731.x-BIB38|cit38","first-page":"R1366","article-title":"Spinal and peripheral mechanisms contributing to hyperactive voiding in spontaneously hypertensive rats","volume":"275","author":"Persson","year":"1998","journal-title":"Am J Physiol"},{"key":"10.1111\/j.1742-1241.2011.02731.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"R682","DOI":"10.1152\/ajpregu.00349.2002","article-title":"Erectile dysfunction in spontaneously hypertensive rats: pathophysiological mechanisms","volume":"284","author":"Behr-Roussel","year":"2003","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1111\/j.1742-1241.2011.02731.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1097\/01.ju.0000173072.73702.64","article-title":"Autonomic nervous system overactivity in men with lower urinary tract symptoms secondary to benign prostatic hyperplasia","volume":"174","author":"McVary","year":"2005","journal-title":"Eur Urol"},{"issue":"Suppl. 1","key":"10.1111\/j.1742-1241.2011.02731.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1046\/j.1464-410X.1998.0820s1026.x","article-title":"Age related erectile and voiding dysfunction: the role of arterial insufficiency","volume":"82","author":"Tarcan","year":"1998","journal-title":"Br J Urol"},{"key":"10.1111\/j.1742-1241.2011.02731.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1016\/S0022-5347(05)68995-1","article-title":"Atherosclerosis-induced chronic ischemia causes bladder fibrosis and non-compliance in the rabbit","volume":"161","author":"Azadzoi","year":"1999","journal-title":"J Urol"},{"key":"10.1111\/j.1742-1241.2011.02731.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/S0022-5347(05)66595-0","article-title":"Chronic ischemia alters prostate structure and reactivity in rabbits","volume":"165","author":"Kozlowski","year":"2001","journal-title":"J Urol"},{"key":"10.1111\/j.1742-1241.2011.02731.x-BIB44|cit44","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1097\/01.ju.0000064923.29954.7e","article-title":"Chronic ischemia increases prostatic smooth muscle contraction in the rabbit","volume":"170","author":"Azadzoi","year":"2003","journal-title":"J Urol"},{"key":"10.1111\/j.1742-1241.2011.02731.x-BIB45|cit45","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.eururo.2009.09.035","article-title":"The effects of combination therapy with dutasteride and tamsulosin on clinical outcomes in men with symptomatic benign prostatic hyperplasia: 4-year results from the CombAT study","volume":"57","author":"Roehrborn","year":"2010","journal-title":"Eur Urol"},{"key":"10.1111\/j.1742-1241.2011.02731.x-BIB46|cit46","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa030656","article-title":"The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia","volume":"349","author":"McConnell","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1742-1241.2011.02731.x-BIB47|cit47","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0090-4295(02)01905-2","article-title":"Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia","volume":"60","author":"Roehrborn","year":"2002","journal-title":"Urology"},{"key":"10.1111\/j.1742-1241.2011.02731.x-BIB48|cit48","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1056\/NEJM199802263380901","article-title":"The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia","volume":"338","author":"McConnell","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1742-1241.2011.02731.x-BIB49|cit49","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.urology.2008.06.048","article-title":"Ejaculatory dysfunction and its association with lower urinary tract symptoms of benign prostatic hyperplasia and BPH treatment","volume":"74","author":"Hellstrom","year":"2009","journal-title":"Urology"},{"key":"10.1111\/j.1742-1241.2011.02731.x-BIB50|cit50","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0090-4295(02)02401-9","article-title":"Incidence and severity of sexual adverse experiences in finasteride and placebo-treated men with benign prostatic hyperplasia","volume":"61","author":"Wessells","year":"2003","journal-title":"Urology"},{"key":"10.1111\/j.1742-1241.2011.02731.x-BIB51|cit51","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1464-410X.2005.05909.x","article-title":"Long-term therapy with the dual 5alpha-reductase inhibitor dutasteride is well tolerated in men with symptomatic benign prostatic hyperplasia","volume":"97","author":"Schulman","year":"2005","journal-title":"BJU Int"},{"key":"10.1111\/j.1742-1241.2011.02731.x-BIB52|cit52","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1016\/j.juro.2009.02.034","article-title":"Rapid efficacy of the highly selective alpha1A-adrenoceptor antagonist silodosin in men with signs and symptoms of benign prostatic hyperplasia: pooled results of 2 phase 3 studies","volume":"181","author":"Marks","year":"2009","journal-title":"J Urol"},{"key":"10.1111\/j.1742-1241.2011.02731.x-BIB53|cit53","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/ncpuro0836","article-title":"Pharmacology of alpha1-adrenoceptor antagonists in the lower urinary tract and central nervous system","volume":"4","author":"Andersson","year":"2007","journal-title":"Nat Clin Pract Urol"},{"issue":"Suppl. 1","key":"10.1111\/j.1742-1241.2011.02731.x-BIB54|cit54","first-page":"S1","article-title":"Efficacy of \u03b1-adrenergic receptor blockers in the treatment of male lower urinary tract symptoms","volume":"11","author":"Roehrborn","year":"2009","journal-title":"Rev Urol"},{"key":"10.1111\/j.1742-1241.2011.02731.x-BIB55|cit55","first-page":"CD002081","article-title":"Tamsulosin for benign prostatic hyperplasia","volume":"1","author":"Wilt","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/j.1742-1241.2011.02731.x-BIB56|cit56","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0090-4295(98)00127-7","article-title":"Long-term evaluation of tamsulosin in benign prostatic hyperplasia: placebo-controlled, double-blind extension of phase III trial","volume":"51","author":"Lepor","year":"1998","journal-title":"Urology"},{"key":"10.1111\/j.1742-1241.2011.02731.x-BIB57|cit57","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/sj.ijir.3901540","article-title":"Physician perceptions of sexual dysfunction related to benign prostatic hyperplasia (BPH) symptoms and sexual side effects related to BPH medications","volume":"19","author":"Seftel","year":"2007","journal-title":"Int J Impot Res"},{"key":"10.1111\/j.1742-1241.2011.02731.x-BIB58|cit58","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1097\/01.ju.0000067940.76090.73","article-title":"Sexual dysfunction in 1,274 European men suffering from lower urinary tract symptoms","volume":"169","author":"Vallancien","year":"2003","journal-title":"J Urol"},{"key":"10.1111\/j.1742-1241.2011.02731.x-BIB59|cit59","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1111\/j.1743-6109.2007.00563.x","article-title":"Finasteride 5\u2003mg and sexual side effects: how many of these are related to a nocebo phenomenon?","volume":"4","author":"Mondaini","year":"2007","journal-title":"J Sex Med"},{"key":"10.1111\/j.1742-1241.2011.02731.x-BIB60|cit60","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1016\/j.ehj.2003.08.016","article-title":"Report of erectile dysfunction after therapy with beta-blockers is related to patient knowledge of side effects and is reversed by placebo","volume":"24","author":"Silvestri","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1111\/j.1742-1241.2011.02731.x-BIB61|cit61","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1001\/jama.287.5.622","article-title":"Nonspecific medication side effects and the nocebo phenomenon","volume":"287","author":"Barsky","year":"2002","journal-title":"JAMA"},{"key":"10.1111\/j.1742-1241.2011.02731.x-BIB62|cit62","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/S0090-4295(97)00238-0","article-title":"The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction","volume":"49","author":"Rosen","year":"1997","journal-title":"Urology"},{"key":"10.1111\/j.1742-1241.2011.02731.x-BIB63|cit63","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/sj.ijir.3900472","article-title":"Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction","volume":"11","author":"Rosen","year":"1999","journal-title":"Int J Impot Res"},{"key":"10.1111\/j.1742-1241.2011.02731.x-BIB64|cit64","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.urology.2007.02.036","article-title":"Development and validation of four-item version of the Male Sexual Health Questionnaire to assess ejaculatory dysfunction","volume":"69","author":"Rosen","year":"2007","journal-title":"Urology"},{"key":"10.1111\/j.1742-1241.2011.02731.x-BIB65|cit65","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1046\/j.1524-4733.2001.44021.x","article-title":"Reproducibility and clinical and concurrent validity of the MSF-4: a four-item male sexual function questionnaire for patients with benign prostatic hyperplasia","volume":"4","author":"Marquis","year":"2001","journal-title":"Value Health"},{"key":"10.1111\/j.1742-1241.2011.02731.x-BIB66|cit66","first-page":"1661","article-title":"Reproducibility and clinical and concurrent validity of the MSF-4: a four-item male sexual function questionnaire for patients with benign prostatic hyperplasia","volume":"168","author":"Kaplan","year":"2002","journal-title":"J Urol"},{"key":"10.1111\/j.1742-1241.2011.02731.x-BIB67|cit67","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1080\/08038020310021967","article-title":"Effect of the angiotensin II antagonist valsartan on sexual function in hypertensive men","volume":"2","author":"D\u00fcsing","year":"2003","journal-title":"Blood Press Suppl"},{"key":"10.1111\/j.1742-1241.2011.02731.x-BIB68|cit68","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s11934-007-0049-x","article-title":"The importance of risk factor reduction in erectile dysfunction","volume":"8","author":"Jackson","year":"2007","journal-title":"Curr Urol Rep"},{"key":"10.1111\/j.1742-1241.2011.02731.x-BIB69|cit69","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1743-6109.2008.01030.x","article-title":"Effects of intensive lifestyle changes on erectile dysfunction in men","volume":"6","author":"Esposito","year":"2009","journal-title":"J Sex Med"},{"key":"10.1111\/j.1742-1241.2011.02731.x-BIB70|cit70","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/j.eururo.2008.01.075","article-title":"A randomised, placebo-controlled study to assess the efficacy of twice-daily vardenafil in the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia","volume":"53","author":"Stief","year":"2008","journal-title":"Eur Urol"},{"key":"10.1111\/j.1742-1241.2011.02731.x-BIB71|cit71","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/j.urology.2009.09.093","article-title":"Effects of tadalafil on lower urinary tract symptoms secondary to benign prostatic hyperplasia in men with or without erectile dysfunction","volume":"75","author":"Broderick","year":"2010","journal-title":"Urology"}],"container-title":["International Journal of Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1742-1241.2011.02731.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1742-1241.2011.02731.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T06:10:43Z","timestamp":1712556643000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1742-1241.2011.02731.x"}},"subtitle":["BPH treatment: impact on sexual function and management of related sexual adverse events"],"short-title":[],"issued":{"date-parts":[[2011,7,1]]},"references-count":71,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2011,9]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1742-1241.2011.02731.x","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717950451.793455701","asserted-by":"object"}]},"ISSN":["1368-5031"],"issn-type":[{"value":"1368-5031","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7,1]]}}}